TriSalus Life Sciences logo

TriSalus Life Sciences

TLSI | NASDAQ
Chart Builder DCF Calculator
$2.27
-$0.16 (-6.58%)
At close: Nov 16, 2026, 4:00 PM ET
$2.27
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-6.58%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
52.2
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #236/1021 (Top 23%)

Key Statistics

Market Data

Market Cap $140.06M
1D Range
2.17 2.57
52W Range
2.17 7.50

Valuation (TTM)

PE -4.63
PB 205.97
EV/EBITDA -6.71

Valuation (NTM)

Forward PE 83.33
Forward PEG 0.07
Price Target $12.00
Loading financial charts...

Profile

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver an...

Sector Healthcare
Employees 102
IPO Date Feb 8, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.15
Miss -18.02%
REV
$12.88M
Miss -8.12%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$12.00
Upside
+428.63%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.